Enterobacteria impair host p53 tumor suppressor activity through mRNA destabilization

被引:0
|
作者
Marie-Stéphanie Aschtgen
Konstantinos Fragkoulis
Gema Sanz
Staffan Normark
Galina Selivanova
Birgitta Henriques-Normark
Sylvain Peuget
机构
[1] Department of Microbiology,Clinical Microbiology
[2] Tumor and Cell Biology,undefined
[3] Karolinska Institute,undefined
[4] Karolinska University Hospital,undefined
来源
Oncogene | 2022年 / 41卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Increasing evidence highlights the role of bacteria in the physiopathology of cancer. However, the underlying molecular mechanisms remains poorly understood. Several cancer-associated bacteria have been shown to produce toxins which interfere with the host defense against tumorigenesis. Here, we show that lipopolysaccharides from Klebsiella pneumoniae and other Enterobacteria strongly inhibit the host tumor suppressor p53 pathway through a novel mechanism of p53 regulation. We found that lipopolysaccharides destabilize TP53 mRNA through a TLR4-NF-κB-mediated inhibition of the RNA-binding factor Wig-1. Importantly, we show that K. pneumoniae disables two major tumor barriers, oncogene-induced DNA damage signaling and senescence, by impairing p53 transcriptional activity upon DNA damage and oncogenic stress. Furthermore, we found an inverse correlation between the levels of TLR4 and p53 mutation in colorectal tumors. Hence, our data suggest that the repression of p53 by Enterobacteria via TLR4 alleviates the selection pressure for p53 oncogenic mutations and shapes the genomic evolution of cancer.
引用
收藏
页码:2173 / 2186
页数:13
相关论文
共 50 条
  • [21] Copper alters the transciptional activity of the tumor suppressor protein p53
    Zeidan, NT
    VanLandingham, JW
    Levenson, CW
    [J]. FASEB JOURNAL, 2003, 17 (05): : A1127 - A1128
  • [22] Restoring p53 tumor suppressor activity as an anticancer therapeutic strategy
    Martinez, Jesse D.
    [J]. FUTURE ONCOLOGY, 2010, 6 (12) : 1857 - 1862
  • [23] Drosophila p53 is a structural and functional homolog of the tumor suppressor p53
    Ollmann, M
    Young, LM
    Di Como, CJ
    Karim, F
    Belvin, M
    Robertson, S
    Whittaker, K
    Demsky, M
    Fisher, WW
    Buchman, A
    Duyk, G
    Friedman, L
    Prives, C
    Kopczynski, C
    [J]. CELL, 2000, 101 (01) : 91 - 101
  • [24] Long noncoding RNAs required for p53 tumor suppressor activity
    Agami, R.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S45 - S45
  • [25] Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide
    Bernal, Federico
    Tyler, Andrew F.
    Korsmeyer, Stanley J.
    Walensky, Loren D.
    Verdine, Gregory L.
    [J]. Journal of the American Chemical Society, 2007, 129 (09): : 2456 - 2457
  • [26] Pseudokinase Tribbles 1 (TRB1) Negatively Regulates Tumor-Suppressor Activity of p53 through p53 Deacetylation
    Miyajima, Chiharu
    Inoue, Yasumichi
    Hayashi, Hidetoshi
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2015, 38 (04) : 618 - 624
  • [27] The role of the tumor suppressor p53 in spermatogenesis
    Tim L Beumer
    Hermien L Roepers-Gajadien
    Iris S Gademan
    Paul PW van Buul
    Gabriel Gil-Gomez
    Derek H Rutgers
    Dirk G de Rooij
    [J]. Cell Death & Differentiation, 1998, 5 : 669 - 677
  • [28] Activation of the p53 tumor suppressor protein
    Vousden, KH
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2002, 1602 (01): : 47 - 59
  • [29] Regulation of the p53 tumor suppressor protein
    Oren, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (51) : 36031 - 36034
  • [30] Tumor suppressor P53: Regulation and function
    Somasundaram, K
    El-Deiry, WS
    [J]. FRONTIERS IN BIOSCIENCE, 2000, 5 : D424 - D437